Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
57,255,104
-
Share change
-
-885,081
-
Total reported value
-
$237,036,323
-
Put/Call ratio
-
182%
-
Price per share
-
$4.14
-
Number of holders
-
126
-
Value change
-
-$4,356,453
-
Number of buys
-
48
-
Number of sells
-
39
Institutional Holders of ZIOPHARM ONCOLOGY INC - COM (TCRT) as of Q4 2017
As of 31 Dec 2017,
ZIOPHARM ONCOLOGY INC - COM (TCRT) was held by
126 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
57,255,104 shares.
The largest 10 holders included
Third Security, LLC, BlackRock Inc., Vanguard Group Inc, STATE STREET CORP, MILLER VALUE PARTNERS, LLC, MSD Partners, L.P., SUSQUEHANNA INTERNATIONAL GROUP, LLP, NORTHERN TRUST CORP, MORGAN STANLEY, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
126
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.